Login to Your Account

Financings Roundup

OncoGenex Bolsters Pipeline Work via $50M Public Offering

By Jennifer Boggs

Wednesday, October 20, 2010
OncoGenex Pharmaceuticals Inc. took advantage of a recent stock bump to boost its cash position via a $50 million public offering. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription